Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the immunogenicity and safety of Ad26.RSV.preF-based vaccine and quadrivalent high-dose seasonal influenza vaccine when administered either concomitantly or separately.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05071313
Study type Interventional
Source Janssen Vaccines & Prevention B.V.
Contact Study Contact
Phone 844-434-4210
Email [email protected]
Status Not yet recruiting
Phase Phase 3
Start date October 4, 2021
Completion date May 20, 2022